When we think of having a sense of purpose and connection at work, our minds typically turn to careers that […]
Employee Resilience Program Reduces Burnout by 30% at Large Pharmaceutical Company
Summary
A large pharmaceutical company partnered with meQuilibrium to build a measurable, scalable employee resilience program during the COVID-19 pandemic. The results:
- 30% reduction in employee burnout symptoms
- 25% drop in moderate-to-severe generalized anxiety disorder symptoms
- 16% decline in moderate-to-severe depression symptoms
- 74% improvement in stress management
- 40% improvement in work-life balance
- 68% employee enrollment rate (14,000+ employees)
- 70% of enrolled employees engage monthly
- 22.5% of eligible employees enrolled within the first 2 weeks of launch
Overview: Why a Pharmaceutical Company Chose meQ for Workforce Resilience
The COVID-19 pandemic created a prolonged, distributed stress event for employers everywhere. For this large pharmaceutical company, the disruption looked different depending on the role: frontline scientific staff continued working onsite, other employees shifted to remote work, and many teams were suddenly reprioritized to support pandemic-related research and operations.
Leadership recognized a critical truth that's now central to modern workforce strategy: employee resilience and well-being directly drive business performance. To help their people stay resilient through sustained disruption, the company turned to meQ's employee resilience and well-being platform.
The Challenge: Measuring and Building Resilience at Scale
HR leaders knew their company's performance was tied to the psychological resilience of their workforce, but they lacked the tools to measure it. Faced with a classic "build vs. buy" decision, the team evaluated the market and determined that meQ's combination of resilience-building program with workforce intelligence and analytics was the right fit.
The Root Problem: A Gap in Mental Health Support
Several structural gaps made this an urgent priority:
- At least half of people with a diagnosable mental health condition never seek treatment, often due to stigma, or because they don't recognize their symptoms as something they don't have to live with.
- Traditional EAP (Employee Assistance Program) resources reach less than 5% of employees who could benefit from support for depression, anxiety, or chronic stress.
- Even when the company expanded access to well-being content — videos, articles, webinars — HR had no reliable way to measure what was actually working or moving the needle on employee mental health.
This combination of low engagement, low visibility, and unmeasured impact is exactly the gap meQ's platform was built to close.
The Solution: A Scalable Employee Resilience Platform With Built-In Analytics
meQuilibrium's approach combined personalized well-being support with organization-wide workforce intelligence:
- Manager empathy training at scale. Equipping managers organization-wide with the skills to support employees through disruption and uncertainty.
- Personalized, risk-based well-being support. Employees identified through assessment as high-risk for anxiety or burnout received tailored resilience-building interventions.
- Population-level analytics and insights. Aggregated data from employee assessments gave HR leaders visibility into which populations were most at risk, enabling proactive, targeted intervention instead of one-size-fits-all wellness content.
Results: Measurable Improvements in Burnout, Anxiety, and Depression
With strong executive sponsorship and an internal launch campaign led by company leadership, adoption exceeded expectations:
- 22.5% of the eligible population enrolled within the first two weeks, a record-breaking launch.
- Over 50% of the workforce was actively enrolled and using meQ within 7 months.
- More than 14,000 employees enrolled, an overall enrollment rate of 68%.
- 70% of enrolled employees engage with the platform monthly, indicating sustained behavior change rather than one-time sign-up.
Employee Well-being Outcomes
| Metric | Improvement |
|---|---|
| Stress management | +74% |
| Work-life balance | +40% |
| Burnout symptoms | -30% |
| Generalized anxiety disorder (moderate or worse) | -25% |
| Depression symptoms (moderate or worse) | -16% |
These outcomes reflect a broader trend confirmed across meQ's enterprise clients: when employees have access to personalized, resilience tools, mental health risk factors decline measurably, and engagement sustains over time.
Looking Ahead: Building a Culture of Resilience
The pharmaceutical company's HR team is now expanding the program by organizing managers and leaders into cohorts based on shared resilience factors, creating a common language and framework for supporting team emotional well-being. This positions the organization to predict and prevent workforce mental health risks — not just react to them — as it navigates future workplace disruptions.
Why This Matters for HR and Benefits Leaders
This case study illustrates a pattern relevant to any organization evaluating employee well-being platforms, resilience training programs, or workforce mental health analytics:
- Generic wellness content and standalone EAPs are not sufficient to reach or measurably improve employee mental health at scale.
- Combining personalized, risk-based interventions with organization-wide workforce analytics drives both higher engagement and better outcomes.
- Executive sponsorship and internal championing significantly accelerate adoption.
Ready to Build a More Resilient Workforce?
Learn how meQ's employee resilience platform can help your organization reduce burnout, lower mental health risk, and build a measurable culture of well-being.
Talk to a meQ Specialist Today →
FAQ: Common Questions About This Case Study
How much did burnout decline after implementing meQ? Employee burnout symptoms declined by 30% following the rollout of meQ's resilience and wellbeing platform.
What was the employee enrollment rate? More than 14,000 employees enrolled, representing a 68% enrollment rate, with 70% of enrolled employees engaging monthly.
How does meQ differ from a traditional EAP? Traditional EAPs typically reach fewer than 5% of employees who could benefit from mental health support. meQ combines personalized, assessment-based interventions with population-level analytics to reach and engage a much larger share of the workforce.
What outcomes did employees see in anxiety and depression symptoms? Symptoms consistent with moderate or worse generalized anxiety disorder dropped by 25%, and moderate or worse depression symptoms declined by 16%.
